trial
as of 2026-07-01Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for Psychosis
NCTId NCT00396643
at a glance
Phase 4 · Completed
Enrollment 81 (actual)
Sponsored by Medical University of Vienna
Primary completion 2007-06
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
81 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2004-05
Primary completion
2007-06
Eligibility
ALL · 13 Years · 25 Years
Interventions & indications
Sponsors
Medical University of ViennaLead Sponsor
Stanley Medical Research InstituteCollaborator
Investigators
1
G Paul Amminger, MDPrincipal Investigator
Sites
1 total
Vienna, Austria
Facts & assertions
4 sourced
Enrollment
81
Phase
PHASE4
Primary Completion Date
2007-06
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
investigator
person